REGENXBIO SINKS AS FDA PUTS RGX-121 GENE THERAPY ON CLINICAL HOLD - SEEKINGALPHA

FDA clinical hold on RGX-121 triggers regulatory uncertainty, driving sharp downside for REGENXBIO.